Selective human adenosine A3 antagonists based on pyrido[2,1-f]purine-2,4-diones: novel features of hA3 antagonist binding. (Q34713557)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000937%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Selective human adenosine A3 antagonists based on pyrido[2,1-f]purine-2,4-diones: novel features of hA3 antagonist binding (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000937%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000937%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

María Jésus Pérez Pérez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000937%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Adriaan P IJzerman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000937%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

María-José Camarasa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000937%20AND%20SRC:MED&resulttype=core&format=json

Sonsoles Martín-Santamaría

26 December 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000937%20AND%20SRC:MED&resulttype=core&format=json

Jacobien K von Frijtag Drabbe Kuenzel

26 December 2019

3

object named as

Jacobien K von Frijtag Drabbe Kuenzel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000937%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Henk de Vries

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000937%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000937%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000937%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000937%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000937%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

111-119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000937%20AND%20SRC:MED&resulttype=core&format=json

Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Hemodynamic effects and histamine release elicited by the selective adenosine A3 receptor agonist 2-Cl-IB-MECA in conscious rats

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

A3 adenosine receptor-mediated protection of the ischemic heart

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

A glance at adenosine receptors: novel target for antitumor therapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Structure-activity relationships of adenosine A3 receptor ligands: new potential therapy for the treatment of glaucoma

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Progress in the pursuit of therapeutic adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Recent developments in the field of A3 adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Medicinal chemistry of adenosine A3 receptor ligands

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Pyrido[2,1-f]purine-2,4-dione derivatives as a novel class of highly potent human A(3) adenosine receptor antagonists.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

A manual method for applying the Hansch approach to drug design

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

4-amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as new potent and selective human A3 adenosine receptor antagonists. synthesis, pharmacological evaluation, and ligand-receptor modeling studies.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Fluorosulfonyl-substituted xanthines as selective irreversible antagonists for the A(1)-adenosine receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

A1 adenosine receptor antagonists as ligands for positron emission tomography (PET) and single-photon emission tomography (SPET).

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Crystal structure of rhodopsin: A G protein-coupled receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Anatomy of protein pockets and cavities: measurement of binding site geometry and implications for ligand design

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Novel amino acid derived natural products from the ascidian Atriolum robustum: identification and pharmacological characterization of a unique adenosine derivative

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Molecular dynamics simulation of the human adenosine A3 receptor: agonist induced conformational changes of Trp243.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Comparative binding energy analysis of HIV-1 protease inhibitors: incorporation of solvent effects and validation as a powerful tool in receptor-based drug design.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700173

7 January 2021

Identifiers

DOI

10.1002/CMDC.200700173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000937%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference